Evaluation of relationship between HbA1c levels and ovarian reserve in patients with type 1 diabetes mellitus

References

• Cai L, Li W, Wang G, et al. Hyperglycemia-induced apoptosis in mouse myocardium: mitachondrial cyto-chrome c-mediated caspase-3 activation pathway. Diabetes. 2002;51(6):1938–1948.
   PubMed Web of Science ®Google Scholar
• Zarzycki W, Zieniewicz M. Reproductive disturbances in type 1 diabetic women. Neuro Endocrinol Lett. 2005;26(6):733–738.
   PubMed Web of Science ®Google Scholar
• Dorman JS, Steenkiste AR, Foley TP, et al. Familial autoimmune and diabetes (FAD) study: menopause in type 1 diabetic women: is it premature? Diabetes. 2001;50(8):1857–1862.
   PubMed Web of Science ®Google Scholar
• Petrikova J, Lazurova I. Ovarian failure and polycystic ovary syndrome. Autoimmun Rev. 2012;11(6–7):A471–A478.
   PubMed Web of Science ®Google Scholar
• Li L, Jing Y, Dong MZ, et al. Type 1 diabetes affects zona pellucida and genome methylation in oocytes and granulosa cells. Mol Cell Endocrinol. 2020;500:110627.
   PubMed Web of Science ®Google Scholar
• Yarde F, Spiering W, Franx A, et al. OVADIA Study Group. Association between vascular health and ovarian ageing in type 1 diabetes mellitus. Hum Reprod. 2016;31(6):1354–1362.
   PubMed Web of Science ®Google Scholar
• Monniaux D, Clement F, Dalbies Tran R, et al. The ovarian reserve of primordial follicles and the dynamic reserve of antral growing follicles: what is the link? Biol Reprod. 2014;90(4):85.
   PubMed Web of Science ®Google Scholar
• Hendriks DJ, Kwee J, Mol BW, et al. Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril. 2007;87(4):764–775.
   PubMed Web of Science ®Google Scholar
• Lawrenz B, Henes J, Henes M, et al. Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-muellerian hormone. Lupus. 2011;20(11):1193–1197.
   PubMed Web of Science ®Google Scholar
• SenateS E, Colak Y, Erdem ED, et al. Serum anti-mullerian hormone levels are lower in reproductive-age women with Crohn’s disease compared to healthy control women. J Crohns Colitis. 2013;7(2):e29–e34.
   PubMedGoogle Scholar
• Anckaert E, Oktem M, Thies A, et al. Multicenter analytical performance evaluation of a fully automated anti-mullerian hormone assay and reference interval determination. Clin Biochem. 2016;49(3):260–267.
   PubMed Web of Science ®Google Scholar
• Leonhardt H, Gull B, Stener-Victorin E, et al. Ovarian volume and antral follicle count assessed by MRI and transvaginal ultrasonography: a methodological study. Acta Radiol. 2014;55(2):248–256.
   PubMed Web of Science ®Google Scholar
• Tuten A, Hatipoglu E, Oncul M, et al. Evaluation of ovarian reserve in Hashimoto's thyroiditis. Gynecol Endocrinol. 2014;30(10):708–711.
   PubMed Web of Science ®Google Scholar
• Jirge PR. Ovarian reserve tests. J Hum Reprod Sci. 2011;4(3):108–113.
   PubMedGoogle Scholar
• De Vet A, Laven JS, de Jong FH, et al. Anti-mullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002;77(2):357–362.
   PubMed Web of Science ®Google Scholar
• van Rooij IA, Broekmans FJ, Scheffer GJ, et al. Serum anti-mullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005;83(4):979–987.
   PubMed Web of Science ®Google Scholar
• Visser JA, de Jong FH, Laven JSE, et al. Anti-mullerian hormone: a new marker for ovarian function. Reproduction. 2006;131(1):1–9.
   PubMed Web of Science ®Google Scholar
• Faddy MJ, Gosden RG, Gougeon A, et al. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992;7(10):1342–1346.
   PubMed Web of Science ®Google Scholar
• Kim C, , Dunn RL, Braffett B, et al. Ovarian reserve in women with type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabet Med. 2016;33(5):691–692.
   PubMed Web of Science ®Google Scholar
• Morel N, Bachelot A, Chakhtoura Z, et al. Study of anti-mullerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide. J Clin Endocrinol Metab. 2013;98(9):3785–3792.
   PubMed Web of Science ®Google Scholar
• Clowse ME, Copland SC, Hsieh TC, et al. Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener’s). Arthritis Care Res. 2011;63(12):1777–1781.
   Web of Science ®Google Scholar
• Brouwer J, Laven JS, Hazes JM, et al. Levels of serum anti-mullerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013;65(9):1534–1538.
   PubMed Web of Science ®Google Scholar
• Soto N, Iñiguez G, López P, et al. Anti-mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus. Hum Reprod. 2009;24(11):2838–2844.
   PubMed Web of Science ®Google Scholar
• Yarde F, van der Schouw YT, de Valk HW, et al. Age at menopause in women with type 1 diabetes mellitus: the OVADIA study. Hum Reprod. 2015;30(2):441–446.
   PubMed Web of Science ®Google Scholar
• Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058–1070.
   PubMed Web of Science ®Google Scholar
• Karasu C. Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatment. Open Cardiovasc Med J. 2010;4(1):240–256.
   PubMedGoogle Scholar
• Kuida K, Lippke JA, Ku G, et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science. 1995;267(5206):2000–2003.
   PubMed Web of Science ®Google Scholar
• Tatone C, Amicarelli F, Carbone MC, et al. Cellular and molecular aspects of ovarian follicle ageing. Hum Reprod Update. 2008;14(2):131–142.
   PubMed Web of Science ®Google Scholar
• Allen DA, Yaqoob MM, Harwood SM. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J Nutr Biochem. 2005;16(12):705–713.
   PubMed Web of Science ®Google Scholar
• Cahng AS, Dale AN, Moley KH. Maternal diabetes adversely affects preovulatory oocyte maturation, development, and granulosa cell apoptosis. Endocrinology. 2005;146(5):2445–2453.
   PubMed Web of Science ®Google Scholar
• Yeshaya A, Orvieto R, Dicker D, et al. Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. Int J Fertil Menopausal Stud. 1995;40(5):269–273.
   PubMedGoogle Scholar
• Nayki U, Onk D, Balci G, et al. The effects of diabetes mellitus on ovarian injury and reserve: an experimental study. Gynecol Obstet Invest. 2016;81(5):424–429.
   PubMed Web of Science ®Google Scholar
• Sherman BM, West JH, Korenman SG. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab. 1976;42(4):629–636.
   PubMed Web of Science ®Google Scholar
• Sowers MR, Eyvazzadeh AD, McConnell D, et al. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab. 2008;93(9):3478–3483.
   PubMed Web of Science ®Google Scholar
• Sowers MR, Zheng H, McConnell D, et al. Follicle stimulating hormone and its rate of change in defining menopause transition stages. J Clin Endocrinol Metab. 2008;93(10):3958–3964.
   PubMed Web of Science ®Google Scholar
• Sowers MR, Zheng H, McConnell D, et al. Estradiol rates of change in relation to the final menstrual period in a population-based cohort of women. J Clin Endocrinol Metab. 2008;93(10):3847–3852.
   PubMed Web of Science ®Google Scholar
• Smotrich DB, Widra EA, Gindoff PR, et al. Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril. 1995;64(6):1136–1140.
   PubMed Web of Science ®Google Scholar
• Licciardi FL, Liu HC, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril. 1995;64(5):991–994.
   PubMed Web of Science ®Google Scholar
• Otto-Buczkowska E. The clinical utility of C-peptide measurement in diabetology. Pediatr Endocrino Diabetes Metab. 2014;20(2):63–68.
   Google Scholar